Loading…
Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.
Political giving
$0
Political receipts
$0
Lobbying income
$4,994,025
Lobbying expense
—
Federal awards
—
Relationships
73
| $180,000 |
| — |
| lobbied by | Specialty Pharmacy Coalition | $180,000 | — |
| lobbied by | Bone Growth Stimulator Coalition | $180,000 | — |
| lobbied by | Eli Lilly & Co | $152,416 | — |
| lobbied by | Biogen-Idec | $133,251 | — |
| lobbied by | Healthcare Leadership Council | $133,102 | — |
| lobbied by | Healthcare Leadership Council | $133,093 | — |
| lobbied by | Healthcare Leadership Council | $132,000 | — |
| lobbied by | Biogen-Idec | $132,000 | — |
| lobbied by | Cardinal Health | $121,339 | — |
| lobbied by | Inc. Amgen | $121,008 | — |
| lobbied by | Cardinal Health | $120,000 | — |
| lobbied by | Astrazeneca Pharmaceuticals | $120,000 | — |
| lobbied by | Cardinal Health | $114,000 | — |
| lobbied by | Caremark Rx | $113,596 | — |
| lobbied by | Caremark Rx | $104,500 | — |
| lobbied by | Hoffman-Laroche | $102,223 | — |
| lobbied by | Novartis | $90,420 | — |
| lobbied by | Natl Orthotic Manufacturers Assn | $90,000 | — |
| lobbied by | Specialty Pharmacy Coalition | $90,000 | — |
| lobbied by | Specialty Pharmacy Coalition | $90,000 | — |
| lobbied by | Assn Of Community Cancer Centers | $85,086 | — |
| lobbied by | Assn Of Community Cancer Centers | $84,241 | — |
| lobbied by | Eli Lilly & Co | $75,000 | — |
| lobbied by | Hoffman-Laroche | $71,379 | — |
| lobbied by | Cardinal Health | $69,515 | — |
| lobbied by | Biogen-Idec | $66,355 | — |
| lobbied by | Biogen-Idec | $66,000 | — |
| lobbied by | Deroyal Industries Inc | $61,342 | — |
| lobbied by | Inc. Amgen | $60,000 | — |
| lobbied by | Organogenesis | $60,000 | — |
| lobbied by | Astrazeneca Pharmaceuticals | $60,000 | — |
| lobbied by | Organogenesis | $60,000 | — |
| lobbied by | Joint Commission On Accreditation Of Healthcare Orgs | $55,839 | — |
| lobbied by | Eli Lilly & Co | $50,177 | — |
| lobbied by | Natl Coalition For Assistive & Rehab Technology | $50,000 | — |
| lobbied by | Joint Commission On Accreditation Of Healthcare Orgs | $48,600 | — |
| lobbied by | Natl Orthotic Manufacturers Assn | $45,376 | — |
| lobbied by | American Clinical Laboratory Assn | $45,000 | — |
| lobbied by | Healthcare Leadership Council | $44,292 | — |
| lobbied by | Guilford Pharmaceuticals | $42,280 | — |
| lobbied by | Inc. Amgen | $40,299 | — |
| lobbied by | Caremark Rx | $36,387 | — |
| lobbied by | Joint Commission On Accreditation Of Healthcare Orgs | $32,206 | — |
| lobbied by | Natl Orthotic Manufacturers Assn | $30,615 | — |
| lobbied by | Joint Commission On Accreditation Of Healthcare Orgs | $30,600 | — |
| lobbied by | Guilford Pharmaceuticals | $30,290 | — |